Position in DGX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,665,830
+$1,353,476 QoQ
Shares Held
8,500
+372.2% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
9 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in DGX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026LEVIN CAPITAL STRATEGIES, L.P. holds $20,528,370 across 6 Diagnostics & Research names. DGX ranks #4 (8.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | WAT |
Waters Corp /De/
|
29,535 | $8,795,523 | |
| 2 | LH |
Labcorp Holdings Inc.
|
21,013 | $5,606,478 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
6,291 | $3,092,215 | |
| 4 | DGX |
Quest Diagnostics Inc
This page
|
8,500 | $1,665,830 | |
| 5 | FLGT |
Fulgent Genetics, Inc.
|
43,234 | $687,420 | |
| 6 | RVTY |
Revvity, Inc.
|
7,772 | $680,904 |
All Filings in DGX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,665,830 | 8,500 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $312,354 | 1,800 | Shares | Other | 2026-01-30 | |
| 2025-03-31 | $253,800 | 1,500 | Shares | Other | 2025-05-09 | |
| 2024-12-31 | $1,206,880 | 8,000 | Shares | Other | 2025-02-05 | |
| 2024-09-30 | $931,500 | 6,000 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $372,313 | 2,720 | Shares | Other | 2024-08-07 | |
| 2024-03-31 | $628,279 | 4,720 | Shares | Other | 2024-05-16 | |
| 2020-09-30 | $457,960 | 4,000 | Shares | Other | 2020-11-17 | |
| 2020-06-30 | $376,068 | 3,300 | Shares | Other | 2020-08-18 | |
| No filing history on record for this holder in this stock. | ||||||